Comments on:

Merck sees $200M hit to 2013 results on Venezuela

Back to the article » |
NEW YORK (AP) — Drugmaker Merck & Co. said Wednesday that the devaluation of Venezuela's currency will reduce its net income by about $200 million this year. Merck will take a charge of 5 cents per share in the first quarter as a result of the devaluation of the bolivar. The devaluation will reduce the company's net income by about 2 cents per share over the rest of the year. The Whitehouse...

To learn more about commenting on and our community guidelines, please see our comments FAQ.